Table 2 Baseline data of the experimental population included in the study
Study (year) | Age, y | Male, % | Number of Patients | diabetes duration (year) | BMI (kg/m2) | SBP (mmHg) | HbA1C (%) | Study type |
|---|---|---|---|---|---|---|---|---|
Keith C2019 | 57.2/56.5 | 50/55.1 | 72/78 | 9.3/9.3 | 35.12/36.04 | – | – | RCT |
Kazuomi 2019 | 69.3/70.9 | 52.4/52.9 | 63/68 | 9.6/10.6 | 26/26.1 | – | 6.6/6.6 | RCT |
MichaelA 2015 | 56.2/55.6 | 55/59.3 | 311/302 | 7.6/8.2 | – | 149.5/149.8 | 8.0/8.1 | RCT |
Tikkanen 2015 | 60.3/60.6/59.9 | 62/62/56.5 | 271/276/276 | – | 32.4/32.4/33 | 131.7/131.3/131.2 | 7.9/7.87/7.92 | RCT |
Heerspink 2016 | 55.1/54.8 | 69.8/57.5 | 189/167 | 8.3/8.6 | 31.3/31.6 | 151.4/151.9 | 8.1/8.1 | RCT |
Ferreira1 2020 | – | – | 516/1063 | – | – | – | – | RCT |
Ferreira2 2020 | – | – | 1817/3624 | – | – | – | – | RCT |
LanCheng 2021 | 71.7/71.2 | 59.7/64.5 | 62/62 | – | 25.8/25.5 | 150.8/153.0 | 7.7/7.7 | RCT |
Amin 2011 | – | – | 39/39 | – | – | – | – | RCT |
Raymond 2015 | 58.3/57.8/59.6 | 55.4/59.6/58.9 | 56/57/56 | – | 34.1/33.0/32.9 | 139.6/136.5/136.7 | 8.0/8.1/8.2 | RCT |
Weber 2015 | 57/56 | 58/52 | 224/225 | 7.3/7.7 | – | 151.3/151.0 | 8.0/8.1 | RCT |